Morforex

Molecular structure via molpic based on CDK

Conformer []

Conformer structure via 3Dmol.js

Physical properties []
Molecular mass	248.36 g/mol ^[1]
Predicted LogP	1.8 ^[1]

Structural Identifiers []
Molecular formula	C₁₅H₂₄N₂O ^[1]
IUPAC name	N-(2-morpholin-4-ylethyl)-1-phenylpropan-2-amine ^[1]
SMILES	CC(CC1=CC=CC=C1)NCCN2CCOCC2 ^[1]
InChI	InChI=1S/C15H24N2O/c1-14(13-15-5-3-2-4-6-15)16-7-8-17-9-11-18-12-10-17/h2-6,14,16H,7-13H2,1H3 ^[1]
InChIKey	ISEKMORYCCULAL-UHFFFAOYSA-N ^[1]

Morforex

Morforex (also known as En300-1270352, 4-(2-((α-Methylphenethyl)amino)ethyl)morpholine, [2-(morpholin-4-yl)ethyl](1-phenylpropan-2-yl)amine, 4-(2-((α-Methylphenethyl)-amino)ethyl)morpholine, N-[2-(Morpholin-4-yl)ethyl]-1-phenylpropan-2-amine, Q19598008 or Z1079104726) is a prodrug and stimulant substance of the amphetamine class.

Chemistry

Stereochemistry []

Morforex is a racemic mixture of the enantiomers

Stereoisomers
(R)-Morforex (S)-Morforex

Pharmacology

Morforex acts as a prodrug for:

Active metabolites []
Amphetamine

Subjective effects []

Physical effects
Abnormal heartbeat Appetite suppression Dehydration Dry mouth Increased blood pressure Increased heart rate Increased libido Restless legs Shakiness Stamina enhancement Stimulation Teeth grinding Vasoconstriction

Cognitive effects
Analysis enhancement Cognitive euphoria Compulsive redosing Disinhibition Ego inflation Focus enhancement Increased music appreciation Mania Motivation enhancement Suggestibility suppression Thought acceleration Wakefulness

External links []

References []

National Center for Biotechnology Information. PubChem Compound Summary for CID 3047774, Morforex. Accessed July 19, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/3047774
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Morforex. UNII: O9J6ITY8UX. Global Substance Registration System. Accessed July 19, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/O9J6ITY8UX

Anodyne